Clinical Trial to Compare the Efficacy of Celiprolol to Placebo in Patients With Vascular Ehlers-Danlos Syndrome

Recruiting now · Phase 3 · Has a placebo group

Conditions studied: Vascular Ehlers-Danlos Syndrome

In brief

This is a prospective, Phase 3, randomized, double-blind, placebo-controlled efficacy study to evaluate celiprolol in patients genetically confirmed as COL3A1-positive vEDS using a decentralized clinical trial design.

Key facts

Study ID
NCT05432466
Run by
Acer Therapeutics Inc.
People needed
150
Starts
2022-11-07
Expected to finish
2029-04-01
Last updated by the study team
2025-08-24

Who can join

Age: 15 and older, up to 64. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.